[go: up one dir, main page]

DK437382A - Desoxyribonucleinsyrer, vaerter indeholdende disse, polypeptider samt fremgangsmaader til fremstilling deraf - Google Patents

Desoxyribonucleinsyrer, vaerter indeholdende disse, polypeptider samt fremgangsmaader til fremstilling deraf Download PDF

Info

Publication number
DK437382A
DK437382A DK437382A DK437382A DK437382A DK 437382 A DK437382 A DK 437382A DK 437382 A DK437382 A DK 437382A DK 437382 A DK437382 A DK 437382A DK 437382 A DK437382 A DK 437382A
Authority
DK
Denmark
Prior art keywords
worths
polypeptides
procedures
producing
desoxyribonucleic acids
Prior art date
Application number
DK437382A
Other languages
English (en)
Other versions
DK170714B1 (da
Inventor
Francois Meyer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27261323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK437382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK437382A publication Critical patent/DK437382A/da
Application granted granted Critical
Publication of DK170714B1 publication Critical patent/DK170714B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK437382A 1981-10-03 1982-10-01 Rekombinant DNA-vektor, fremgangsmåde til fremstilling deraf, værter transformeret dermed, fremgangsmåde til fremstilling af transformeret vært samt fremgangsmåde til fremstilling af et lymfoblastoidtalfa-interferon DK170714B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8129937 1981-10-03
GB8129937 1981-10-03
GB8208988 1982-03-26
GB8208988 1982-03-26
GB8224871 1982-09-01
GB08224871A GB2108510B (en) 1981-10-03 1982-09-01 Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Publications (2)

Publication Number Publication Date
DK437382A true DK437382A (da) 1983-04-04
DK170714B1 DK170714B1 (da) 1995-12-18

Family

ID=27261323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK437382A DK170714B1 (da) 1981-10-03 1982-10-01 Rekombinant DNA-vektor, fremgangsmåde til fremstilling deraf, værter transformeret dermed, fremgangsmåde til fremstilling af transformeret vært samt fremgangsmåde til fremstilling af et lymfoblastoidtalfa-interferon

Country Status (19)

Country Link
US (1) US5089400A (da)
EP (1) EP0076489B1 (da)
JP (2) JPH06104066B2 (da)
KR (1) KR920007665B1 (da)
AU (1) AU561104B2 (da)
DD (1) DD204266A5 (da)
DE (1) DE3280174D1 (da)
DK (1) DK170714B1 (da)
ES (2) ES8504936A1 (da)
FI (1) FI80719C (da)
GB (1) GB2108510B (da)
GR (1) GR76992B (da)
HU (1) HU197047B (da)
IE (1) IE54051B1 (da)
IL (1) IL66920A0 (da)
NO (1) NO166494C (da)
NZ (1) NZ202058A (da)
PH (2) PH21524A (da)
PT (1) PT75643B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
DE3220116A1 (de) 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
EP0120906B1 (en) * 1982-10-11 1988-09-21 National Research Development Corporation Polypeptides useful in vaccination against enteroviruses
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0194006B1 (en) * 1985-02-01 1992-04-29 Imperial Chemical Industries Plc Analogous interferon polypeptides, process for their preparation and pharmaceutical compositions containing them
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
IE58766B1 (en) * 1985-04-30 1993-11-03 Takeda Chemical Industries Ltd Production of protein
ATE78262T1 (de) * 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
ATE125304T1 (de) 1986-04-15 1995-08-15 Ciba Geigy Ag Monoklonale antikörper gegen interferon- induziertes humanes protein in gereignigter form, und diese antikörper enthaltende testsätze.
TW218846B (da) * 1992-04-07 1994-01-11 Ciba Geigy
US5834202A (en) * 1992-08-04 1998-11-10 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US6261808B1 (en) 1992-08-04 2001-07-17 Replicon, Inc. Amplification of nucleic acid molecules via circular replicons
WO1994003624A1 (en) * 1992-08-04 1994-02-17 Auerbach Jeffrey I Methods for the isothermal amplification of nucleic acid molecules
US5733733A (en) * 1992-08-04 1998-03-31 Replicon, Inc. Methods for the isothermal amplification of nucleic acid molecules
US20020102236A1 (en) * 1994-12-08 2002-08-01 Taylor Peter William Liposomal interferon hybrid compositions
DE69616276T2 (de) 1995-02-09 2002-12-12 Aventis Pharma Deutschland Gmbh Verfahren zur produktion von proteinen
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6685933B1 (en) * 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
DE19919149A1 (de) * 1999-04-27 2000-11-16 Wieser Raimund J Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere
WO2002036627A2 (en) 2000-11-03 2002-05-10 Pbl Biomedical Laboratories Interferons, uses and compositions related thereto
WO2002088161A1 (en) * 2001-05-02 2002-11-07 Pepgen Corporation Method for expression of human interferon alpha 1 in pichia pa storis
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
EA013263B1 (ru) * 2004-12-20 2010-04-30 Кадила Хелзкэр Лимитед Способ получения интерферона-бета
CN108368405B (zh) 2016-11-21 2019-07-12 日东电工株式会社 粘合片
JP6371931B1 (ja) 2016-11-21 2018-08-08 日東電工株式会社 粘着シート

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
EP0032134B2 (en) * 1980-01-08 1993-10-13 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
IE57069B1 (en) * 1980-04-03 1992-04-22 Biogen Inc Dna sequences,recombinant dna molecules and processes for producing human fibroblast interferon
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
IL66920A0 (en) 1982-12-31
US5089400A (en) 1992-02-18
ES516154A0 (es) 1985-04-16
NZ202058A (en) 1986-05-09
EP0076489A3 (en) 1984-03-28
JPS5890596A (ja) 1983-05-30
JP2612149B2 (ja) 1997-05-21
EP0076489B1 (de) 1990-05-16
NO166494C (no) 1991-08-07
PH23119A (en) 1989-05-05
GB2108510A (en) 1983-05-18
KR920007665B1 (ko) 1992-09-14
FI80719C (fi) 1990-07-10
AU561104B2 (en) 1987-04-30
PH21524A (en) 1987-11-16
DK170714B1 (da) 1995-12-18
NO166494B (no) 1991-04-22
PT75643A (en) 1982-11-01
AU8895882A (en) 1983-04-14
EP0076489A2 (de) 1983-04-13
DD204266A5 (de) 1983-11-23
FI823356L (fi) 1983-04-04
KR840002031A (ko) 1984-06-11
GB2108510B (en) 1984-12-12
DE3280174D1 (de) 1990-06-21
HU197047B (en) 1989-02-28
GR76992B (da) 1984-09-04
ES8504936A1 (es) 1985-04-16
NO823314L (no) 1983-04-05
PT75643B (en) 1986-11-13
JPH07173195A (ja) 1995-07-11
IE54051B1 (en) 1989-05-24
JPH06104066B2 (ja) 1994-12-21
FI823356A0 (fi) 1982-10-01
ES8601237A1 (es) 1985-11-01
FI80719B (fi) 1990-03-30
IE822385L (en) 1983-04-30
ES528141A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
DK437382A (da) Desoxyribonucleinsyrer, vaerter indeholdende disse, polypeptider samt fremgangsmaader til fremstilling deraf
DK75986D0 (da) Alfa, omega-dicarboxylsyrer og fremgangsmaade til fremstilling deraf samt laegemidler indeholdende disse forbindelser
DK247084D0 (da) 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer,fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
DK54382A (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridiner samt fremgangsmaade til fremstilling deraf
DK160792C (da) Soedemiddel samt fremgangsmaade til fremstilling deraf
NO158630C (no) Poroest, tverrbundet polymert blokkmateriale, samt fremgangsmaate for fremstilling av et slikt.
NO171364C (no) N-aryl-3-aryl-4,5-dihydro-1h-pyrazol-1-karboksamider og fremgangsmaate til fremstilling derav, samt insektmiddel sominneholder karboksamidet
NO852937L (no) Antibakterie-forstoffblandinger og framgangsmaate for framstilling av disse.
DK445882A (da) Tryksager samt fremgangsmaade til fremstilling deraf
DK296385A (da) Elektroforesegelmateriale samt fremgangsmaade til fremstilling deraf
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
DK93383A (da) Glycoproteiner samt fremgangsmaade til fremstilling heraf
DK409784D0 (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
DK353083A (da) Kanyleholderkonstruktion samt fremgangsmaade til fremstilling heraf
DK538885A (da) Imidazolylalkylguanidinderivater, fremgangsmaade til fremstillingheraf samt laegemidler indeholdende disse forbindelser
DK115685A (da) Prespap samt fremgangsmaade til fremstilling deraf
DK344979A (da) Kemisk stabiliserede azulminsyrer fremgangsmaade til fremstilling deraf samt disses anvendelse
DK102882A (da) Endo-deoxyribonuklease a samt fremgangsmaade til frembringelseaf samme
DK51785A (da) 1,4-aminoalkylamino-9h-thioxanthen-9-oner, laegemidler indeholdende disse samt fremgangsmaade til fremstilling deraf
DK132782A (da) Organoborankomplekser samt fremgangsmaade til fremstilling deraf
DK161193C (da) Modificerede lerarter samt fremgangsmaade til fremstilling deraf
DK59583D0 (da) Mikroporoes hulfibermembran til plasmaferese samt fremgangsmade til fremstilling deraf
DK504786A (da) Peptidforbindelser samt fremgangsmaade til fremstilling heraf
DK543082A (da) Katalytiske partikler samt fremgangsmaade til fremstilling deraf
DK576482A (da) Aminopropylaminobleomycin-derivater samt fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed